Regent Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $326K | Sell |
4,190
-700
| -14% | -$56.7K | 0.09% | 163 |
|
|
2022
Q3 | $395K | Buy |
4,890
+1,500
| +44% | +$135K | 0.12% | 142 |
|
|
2022
Q2 | $304K | Sell |
3,390
-767
| -18% | -$77.7K | 0.08% | 164 |
|
|
2022
Q1 | $461K | Sell |
4,157
-100
| -2% | -$10.6K | 0.11% | 147 |
|
|
2021
Q4 | $440K | Buy |
4,257
+500
| +13% | +$57.9K | 0.1% | 154 |
|
|
2021
Q3 | $471K | Buy |
3,757
+60
| +2% | +$7.77K | 0.11% | 144 |
|
|
2021
Q2 | $459K | Hold |
3,697
| – | – | 0.11% | 152 |
|
|
2021
Q1 | $437K | Buy |
3,697
+1,150
| +45% | +$135K | 0.11% | 140 |
|
|
2020
Q4 | $298K | Buy |
2,547
+300
| +13% | +$33K | 0.08% | 165 |
|
|
2020
Q3 | $234K | Buy |
+2,247
| New | +$226K | 0.07% | 169 |
|
|
2019
Q4 | – | Sell |
-2,012
| Closed | -$219K | – | 214 |
|
|
2019
Q3 | $219K | Buy |
+2,012
| New | +$210K | 0.07% | 190 |
|
|
2018
Q3 | – | Sell |
-4,200
| Closed | -$360K | – | 205 |
|
|
2018
Q2 | $360K | Sell |
4,200
-200
| -5% | -$16.7K | 0.12% | 154 |
|
|
2018
Q1 | $353K | Hold |
4,400
| – | – | 0.12% | 162 |
|
|
2017
Q4 | $355K | Hold |
4,400
| – | – | 0.12% | 163 |
|
|
2017
Q3 | $342K | Buy |
4,400
+200
| +5% | +$16.6K | 0.12% | 159 |
|
|
2017
Q2 | $373K | Sell |
4,200
-200
| -5% | -$16.9K | 0.13% | 165 |
|
|
2017
Q1 | $354K | Hold |
4,400
| – | – | 0.13% | 154 |
|
|
2016
Q4 | $313K | Buy |
4,400
+200
| +5% | +$15.7K | 0.16% | 144 |
|
|
2016
Q3 | $363K | Hold |
4,200
| – | – | 0.19% | 132 |
|
|
2016
Q2 | $364K | Hold |
4,200
| – | – | 0.2% | 127 |
|
|
2016
Q1 | $315K | Hold |
4,200
| – | – | 0.18% | 138 |
|
|
2015
Q4 | $323K | Sell |
4,200
-800
| -16% | -$60.2K | 0.17% | 142 |
|
|
2015
Q3 | $335K | Sell |
5,000
-6,600
| -57% | -$486K | 0.18% | 133 |
|
|
2015
Q2 | $860K | Sell |
11,600
-4,006
| -26% | -$306K | 0.43% | 71 |
|
|
2015
Q1 | $1.22M | Buy |
15,606
+5
| +0% | +$379 | 0.62% | 46 |
|
|
2014
Q4 | $1.13M | Hold |
15,601
| – | – | 0.58% | 49 |
|
|
2014
Q3 | $967K | Hold |
15,601
| – | – | 0.5% | 63 |
|
|
2014
Q2 | $995K | Hold |
15,601
| – | – | 0.49% | 66 |
|
|
2014
Q1 | $960K | Sell |
15,601
-1,000
| -6% | -$58.3K | 0.51% | 66 |
|
|
2013
Q4 | $953K | Hold |
16,601
| – | – | 0.53% | 65 |
|
|
2013
Q3 | $884K | Buy |
16,601
+600
| +4% | +$32.3K | 0.58% | 65 |
|
|
2013
Q2 | $824K | Buy |
+16,001
| New | +$791K | 0.64% | 57 |
|
Other funds holding MDT
Regent Investment Management's MDT Position: Q4 2022 in Review
Regent Investment Management reduced its Medtronic (MDT) stake by 14% in Q4 2022, selling an estimated $56.7K and leaving 4,190 shares worth $326K. The position accounts for 0.09% of the portfolio, ranked #163.
Regent Investment Management first reported a position in MDT in Q2 2013 and has held it in 32 quarters since. The position peaked at $1.22M in Q1 2015. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.
- Regent Investment Management held 4,190 shares of Medtronic worth $326K as of Q4 2022.
- Regent Investment Management sold 700 Medtronic shares in Q4 2022, an estimated $56.7K.
- Medtronic made up 0.09% of Regent Investment Management's portfolio in Q4 2022, its #163 holding.
- Regent Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 32 quarters since.
- Regent Investment Management's Medtronic position peaked at $1.22M in Q1 2015.
- 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.
Based on Regent Investment Management's 13F filing for Q4 2022, filed 26 Jan 2023.